These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28296710)

  • 41. Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future.
    Dourthe ME; Bolle S; Temam S; Jouin A; Claude L; Reguerre Y; Defachelles AS; Orbach D; Fresneau B
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):85-92. PubMed ID: 29300240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Retrospective analysis of effectiveness of intensity-modulated radiotherapy combined with chemotherapy or not for locoregionally advanced nasopharyngeal carcinoma].
    He F; Luo W; Zhang Q; Guo Y; Liu MZ; Ma J
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(29):2292-5. PubMed ID: 24300148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
    Sun Y; Li WF; Chen NY; Zhang N; Hu GQ; Xie FY; Sun Y; Chen XZ; Li JG; Zhu XD; Hu CS; Xu XY; Chen YY; Hu WH; Guo L; Mo HY; Chen L; Mao YP; Sun R; Ai P; Liang SB; Long GX; Zheng BM; Feng XL; Gong XC; Li L; Shen CY; Xu JY; Guo Y; Chen YM; Zhang F; Lin L; Tang LL; Liu MZ; Ma J
    Lancet Oncol; 2016 Nov; 17(11):1509-1520. PubMed ID: 27686945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.
    Guo SS; Tang LQ; Zhang L; Chen QY; Liu LT; Guo L; Mo HY; Luo DH; Huang PY; Xiang YQ; Sun R; Chen MY; Wang L; Lv X; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    BMC Cancer; 2015 Dec; 15():977. PubMed ID: 26675209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma.
    Imano N; Murakami Y; Nakashima T; Takeuchi Y; Takahashi I; Doi Y; Nishibuchi I; Kimura T; Wadasaki K; Ueda T; Hirakawa K; Nagata Y
    Jpn J Radiol; 2017 Nov; 35(11):673-680. PubMed ID: 28887732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.
    Xiao WW; Huang SM; Han F; Wu SX; Lu LX; Lin CG; Deng XW; Lu TX; Cui NJ; Zhao C
    Cancer; 2011 May; 117(9):1874-83. PubMed ID: 21509764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Zumsteg ZS; Lok BH; Ho AS; Drill E; Zhang Z; Riaz N; Shiao SL; Ma J; McBride SM; Tsai CJ; Baxi SS; Sherman EJ; Lee NY
    Cancer; 2017 Apr; 123(8):1345-1353. PubMed ID: 27984656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dropped head syndrome induced by chemoradiotherapy for nasopharyngeal carcinoma: a case report.
    Hashimoto Y; Maebayashi K; Izumi S; Motegi A; Mitsuhashi N
    Jpn J Clin Oncol; 2012 Nov; 42(11):1091-3. PubMed ID: 22914321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
    Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
    Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
    Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
    Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
    You R; Hua YJ; Liu YP; Yang Q; Zhang YN; Li JB; Li CF; Zou X; Yu T; Cao JY; Zhang MX; Jiang R; Sun R; Mo HY; Guo L; Cao KJ; Lin AH; Sun Y; Qian CN; Ma J; Chen MY
    Theranostics; 2017; 7(8):2314-2324. PubMed ID: 28740554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse.
    Beriwal S; Shukla G; Shinde A; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Richards S; Olawaiye AB; Krivak TC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1269-74. PubMed ID: 23273997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
    Chao HL; Liu SC; Tsao CC; Lin KT; Lee SP; Lo CH; Huang WY; Liu MY; Jen YM; Lin CS
    J Radiat Res; 2017 Sep; 58(5):654-660. PubMed ID: 28992206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
    Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
    Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Encouraging Outcomes With Manageable Toxicity Using Neoadjuvant Chemotherapy and Intensity-modulated Radiotherapy in Advanced Pediatric Nasopharyngeal Carcinoma: Single-Center Experience From a Developing Country.
    Das A; Mallick I; Arun P; Midha D; Sen S; Krishnan S; Bhattacharyya A
    J Pediatr Hematol Oncol; 2017 May; 39(4):318-319. PubMed ID: 28234743
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.